Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12826
PolyPid
PYPD
$90.9M
| $28.6K | ﹤0.01% |
+10,558
| New | +$31.5K |
|
12827
CALL
RF Industries
RFIL
$148M
| $28.6K | ﹤0.01% |
6,100
+5,500
| +917% | +$25.1K |
|
12828
Anghami
ANGH
$31.9M
| $28.6K | ﹤0.01% |
4,301
+2,146
| +100% | +$15.1K |
|
12829
PUT
Alector
ALEC
$219M
| $28.5K | ﹤0.01% |
23,200
-6,400
| -22% | -$10.4K |
|
12830
PUT
Tejon Ranch
TRC
$442M
| $28.5K | ﹤0.01% |
1,800
-5,100
| -74% | -$81.1K |
|
|
GBIO
12831
CALL
DELISTED
Generation Bio
GBIO
| $28.5K | ﹤0.01% |
7,040
+6,480
| +1,157% | +$45.5K |
|
|
TPIC
12832
CALL
DELISTED
TPI Composites
TPIC
| $28.5K | ﹤0.01% |
35,300
-20,300
| -37% | -$26.5K |
|
12833
PUT
SELLAS Life Sciences
SLS
$2.58B
| $28.4K | ﹤0.01% |
26,300
-2,400
| -8% | -$2.85K |
|
12834
CALL
Annexon
ANNX
$1B
| $28.4K | ﹤0.01% |
14,700
-700
| -5% | -$2.33K |
|
12835
PUT
World Kinect Corp
WKC
$1.85B
| $28.4K | ﹤0.01% |
1,000
+900
| +900% | +$25.5K |
|
12836
Freight Technologies
FRGT
$1.05M
| $28.3K | ﹤0.01% |
+296
| New | +$40.9K |
|
|
WOK
12837
WORK Medical Technology Group
WOK
$5.37M
| – | – |
0
| – | – |
|
12838
CALL
Erasca
ERAS
$6.43B
| $28.2K | ﹤0.01% |
20,600
+9,700
| +89% | +$16.6K |
|
12839
CALL
TriMas Corp
TRS
$1.4B
| $28.1K | ﹤0.01% |
1,200
-19,800
| -94% | -$469K |
|
12840
VerifyMe
VRME
$8.66M
| $28.1K | ﹤0.01% |
+41,326
| New | +$57.5K |
|
12841
CALL
GrowGeneration
GRWG
$104M
| $28.1K | ﹤0.01% |
26,000
-42,900
| -62% | -$57.5K |
|
12842
PUT
Maravai LifeSciences
MRVI
$849M
| $28.1K | ﹤0.01% |
12,700
-7,400
| -37% | -$29.2K |
|
12843
PUT
Hagerty
HGTY
$1.32B
| $28K | ﹤0.01% |
3,100
-3,200
| -51% | -$31K |
|
12844
PUT
OFG Bancorp
OFG
$2.28B
| $28K | ﹤0.01% |
700
+400
| +133% | +$16.8K |
|
|
XRN
12845
PUT
Chiron Real Estate Inc
XRN
$491M
| $28K | ﹤0.01% |
640
-2,020
| -76% | -$83.5K |
|
12846
CALL
Citius Pharmaceuticals
CTXR
$20.7M
| $28K | ﹤0.01% |
18,780
+11,684
| +165% | +$28K |
|
12847
CALL
SIGA Technologies
SIGA
$216M
| $27.9K | ﹤0.01% |
5,100
-130,800
| -96% | -$775K |
|
12848
PUT
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $27.9K | ﹤0.01% |
400
-200
| -33% | -$13.9K |
|
|
AMTD
12849
AMTD IDEA Group
AMTD
$72.5M
| $27.9K | ﹤0.01% |
+25,831
| New | +$27.5K |
|
12850
Enveric Biosciences
ENVB
$6.16M
| $27.9K | ﹤0.01% |
1,672
+1,589
| +1,914% | +$55K |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.